Log in
Enquire now
Syneron Medical

Syneron Medical

Syneron Medical is a company developing and marketing aesthetic medical products founded in 1970 by Avi Lior.

OverviewStructured DataIssuesContributors

Contents

syneron.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Healthcare
Healthcare
Location
Marlborough, Massachusetts
Marlborough, Massachusetts
0
Irvine, California
Irvine, California
0
B2X
B2B
B2B
0
Founder
‌
Avi Lior
AngelList URL
angel.co/syneron-medical
Pitchbook URL
pitchbook.com/profiles.../41582-35
Number of Employees (Ranges)
501 – 1,0000
Phone Number
+150835874000
+194971606480
Full Address
251 Locke Drive Marlborough MA 01752 United States of America0
3 Goodyear, Unit A Irvine 92618 United States of America0
Investors
Israel Healthcare Ventures
Israel Healthcare Ventures
Founded Date
1970
0
Stock Symbol
ELOS
Exchange
Nasdaq
Nasdaq
Patents Assigned (Count)
3
Wellfound ID
syneron-medical
Country
United States
United States
0
Headquarters
Irvine, California
Irvine, California

Other attributes

Company Operating Status
Active
Wikidata ID
Q7662405
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Syneron Medical

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.